Home › sodium
 

Keywords :   


Tag: sodium

Trona And Sodium Bicarbonate Passing Field Tests With Flying Colors!

2013-03-14 07:47:20| pollutiononline News Articles

“Quick Facts: Trona and sodium bicarbonate – Passing field tests with flying colors!”will briefly answer some of your most frequently asked questions about recently conducted independent pilot plant tests using Dry Sorbent Injection with trona or sodium bicarbonate.

Tags: field tests colors flying

 

Statement on FOSAMAX (alendronate sodium) Product Liability Trial

2013-03-11 14:30:00| Merck.com - Corporate News

Dateline City:  WHITEHOUSE STATION, N.J. Merck, known as MSD outside the United States and Canada, will vigorously defend itself in a jury trial set to begin today in the Superior Court of New Jersey in Atlantic County. InSu v. Language:  English Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: product statement trial liability

 
 

Jazz Pharmaceuticals Plc And Concert Pharmaceuticals Announce Worldwide Licensing Agreement To Develop And Commercialize Deuterium-Modified Sodium Oxybate

2013-02-26 17:15:00| drugdiscoveryonline News Articles

Jazz Pharmaceuticals plc and Concert Pharmaceuticals, Inc. recently announced an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert’s deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323

Tags: agreement develop worldwide jazz

 

Jazz Pharmaceuticals Plc And Concert Pharmaceuticals Announce Worldwide Licensing Agreement To Develop And Commercialize Deuterium-Modified Sodium Oxybate

2013-02-26 17:15:00| drugdiscoveryonline Home Page

Jazz Pharmaceuticals plc and Concert Pharmaceuticals, Inc. recently announced an exclusive license agreement that provides Jazz Pharmaceuticals worldwide rights to develop and commercialize Concert’s deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323

Tags: agreement develop worldwide jazz

 

Genzyme And Isis Announce FDA Approval Of KYNAMRO (Mipomersen Sodium) Injection For The Treatment Of Homozygous Familial Hypercholesterolemia

2013-01-29 19:30:00| drugdiscoveryonline News Articles

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for KYNAMRO (mipomersen sodium) injection

Tags: treatment approval injection announce

 

Sites : [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »